Immunodiagnostic Systems (IDH.L) stock price, revenue, and financials

Immunodiagnostic Systems market cap is £108.8 m, and annual revenue was £38.51 m in FY 2019

£108.8 M

IDH.L Mkt cap, 07-Jul-2021

£38.5 M

Immunodiagnostic Systems Revenue FY, 2019
Immunodiagnostic Systems Gross profit (FY, 2019)16.7 M
Immunodiagnostic Systems Gross profit margin (FY, 2019), %43.4%
Immunodiagnostic Systems Net income (FY, 2019)796 K
Immunodiagnostic Systems EBITDA (FY, 2019)4.9 M
Immunodiagnostic Systems EBIT (FY, 2019)429 K
Immunodiagnostic Systems Cash, 31-Mar-201927.7 M
Get notified regarding key financial metrics and revenue changes at Immunodiagnostic SystemsLearn more
Banner background

Immunodiagnostic Systems Revenue

Immunodiagnostic Systems revenue was £38.51 m in FY, 2019

Embed Graph

Immunodiagnostic Systems Income Statement

Annual

GBPFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

38.3m40.0m37.9m38.5m

Revenue growth, %

(16%)5%(5%)

Cost of goods sold

15.8m20.1m19.9m21.8m

Gross profit

22.5m19.9m18.0m16.7m

Gross profit Margin, %

59%50%47%43%

Operating expense total

59.3m18.3m17.1m16.3m

EBITDA

(29.8m)6.3m5.5m4.9m

EBITDA margin, %

(78%)16%15%13%

EBIT

(36.8m)1.7m947.0k429.0k

EBIT margin, %

(96%)4%2%1%

Pre tax profit

(37.0m)1.2m935.0k842.0k

Income tax expense

(4.9m)(1.8m)(292.0k)(46.0k)

Net Income

(32.2m)3.0m1.2m796.0k

Immunodiagnostic Systems Balance Sheet

Annual

GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

446.7k885.1k959.8k3.0m4.5m5.3m6.4m11.0m19.6m26.7m23.7m26.6m31.5m28.5m27.7m

Accounts Receivable

922.8k1.3m1.6m4.0m4.4m6.4m7.8m3.6m7.3m5.2m5.4m5.3m6.6m7.4m

Inventories

762.6k805.2k914.6k6.2m5.7m6.4m8.5m7.5m5.9m6.5m6.8m7.5m7.6m8.4m7.8m

Current Assets

2.5m3.3m4.0m14.0m19.4m23.2m27.8m27.4m35.9m42.5m40.7m43.2m48.9m48.4m47.5m

PP&E

618.8k748.2k1.1m3.1m4.2m5.2m8.3m9.5m10.0m9.2m10.3m9.6m8.5m7.5m6.9m

Goodwill

48.7m45.9m9.2m

Total Assets

4.2m5.1m6.5m64.5m80.2m84.3m101.7m92.6m99.2m102.5m97.2m62.3m68.7m67.5m65.9m

Accounts Payable

424.9k365.7k607.2k2.0m2.8m3.2m4.5m2.3m3.6m1.9m2.1m1.5m1.8m2.1m2.4m

Current Liabilities

1.5m1.7m2.0m8.8m10.2m10.1m12.9m13.0m10.9m7.8m7.3m6.4m8.2m7.2m7.3m

Non-Current Liabilities

895.4k563.4k89.1k18.7m19.3m13.3m16.3m7.2m8.5m8.1m9.5m4.2m3.8m3.4m3.3m

Total Debt

208.7k206.0k3.3m2.5m2.6m2.1m4.2m281.0k

Total Liabilities

2.4m2.2m2.1m27.5m29.5m23.3m29.2m20.3m19.4m15.9m16.8m10.6m12.0m10.6m10.6m

Common Stock

266.9k266.9k266.9k479.0k528.3k557.1k559.0k567.0k567.0k583.0k584.0k588.0k588.0k589.0k589.0k

Retained Earnings

43.1m49.6m49.2m16.3m18.9m18.8m17.7m

Total Equity

1.8m2.9m4.4m37.0m50.7m61.0m72.5m72.3m79.8m86.6m80.4m51.7m56.7m57.0m55.3m

Debt to Equity Ratio

0.1 x0.1 x0.1 x0 x0 x0 x0.1 x0 x

Debt to Assets Ratio

0.1 x0 x0.1 x0 x0 x0 x0 x0 x

Financial Leverage

2.4 x1.8 x1.5 x1.7 x1.6 x1.4 x1.4 x1.3 x1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x

Immunodiagnostic Systems Cash Flow

Annual

GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

212.3k916.9k1.6m2.8m4.2m8.1m12.9m4.7m7.8m7.0m2.4m(32.2m)3.0m1.2m796.0k

Cash From Operating Activities

248.2k1.2m2.1m445.0k5.3m9.7m16.5m14.3m18.4m12.3m8.8m8.2m8.4m2.5m5.8m

Dividends Paid

133.4k202.0k360.3k436.3k559.0k708.0k215.0k866.0k2.5m876.0k353.0k1.2m500.0k

Cash From Financing Activities

1.5m(286.7k)(688.7k)24.9m1.9m(1.9m)(5.5m)(2.1m)(5.0m)854.0k(2.6m)(985.0k)(537.0k)(1.4m)(2.0m)

Net Change in Cash

356.7k441.0k74.7k4.0m1.5m820.6k1.1m5.1m8.4m7.2m(2.4m)2.4m4.3m(2.8m)(665.0k)

Income Taxes Paid

(1.4m)(1.7m)4.9m

Immunodiagnostic Systems Ratios

GBPFY, 2005

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

2.4 x

Immunodiagnostic Systems Employee Rating

3.313 votes
Culture & Values
3.7
Work/Life Balance
3.9
Senior Management
3.1
Salary & Benefits
3.2
Career Opportunities
3
Source